Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF
Summary
- Eligibility
- for people ages 40 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- ID
- NCT05389215
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 102 study participants
- Last Updated